TipRanks
Go Ultimate55% OFF

Edward Stelmakh Insider Profile

11 Followers

Edward Stelmakh, Chief Finance & Strat Officer at OptimizeRx, holds 121.79K shares in OptimizeRx (Ticker: OPRX).

Edward Stelmakh's Trading History

OPRX
OptimizeRx
Aug 24, 2026Chief Finance & Strat OfficerUninformative Sell10.65K$1.14M
OPRX
Insider Shares: 121.79K (0.65%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 24, 2026Uninformative Sell$10.65K1,381$7.71―
Dec 23, 2025Uninformative Sell$46.60K3,658$12.74―
Dec 22, 2025Uninformative Buy$52.00K3,849$13.51―
Oct 07, 2025Uninformative Buy$229.07K12,217$18.75―
Aug 25, 2025Uninformative Buy$0.0015,625$0.00―

You May Also Like

Edward Stelmakh insider profile FAQ

What stocks does Edward Stelmakh hold?
Edward Stelmakh holds: OPRX stocks.
What was Edward Stelmakh’s latest transaction?
Edward Stelmakh’s latest transaction was an Uninformative Sell of $10.65K.
What is Edward Stelmakh's role in OptimizeRx?
Edward Stelmakh's role in OptimizeRx is Chief Finance & Strat Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.